Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Bellerophon Therapeutics (PK) (BLPH)

Bellerophon Therapeutics Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:BLPH
DateTimeSourceHeadlineSymbolCompany
04/03/202422:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLPHBellerophon Therapeutics Inc (PK)
01/03/202415:04Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:BLPHBellerophon Therapeutics Inc (PK)
12/02/202420:44Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:BLPHBellerophon Therapeutics Inc (PK)
12/02/202417:39Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:BLPHBellerophon Therapeutics Inc (PK)
12/12/202321:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLPHBellerophon Therapeutics Inc (PK)
14/11/202321:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BLPHBellerophon Therapeutics Inc (PK)
06/11/202321:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:BLPHBellerophon Therapeutics Inc (PK)
07/02/202017:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLPHBellerophon Therapeutics Inc (PK)
29/01/202021:25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLPHBellerophon Therapeutics Inc (PK)
27/01/202021:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
07/01/202013:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BLPHBellerophon Therapeutics Inc (PK)
27/12/201913:26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:BLPHBellerophon Therapeutics Inc (PK)
17/12/201913:25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLPHBellerophon Therapeutics Inc (PK)
25/11/201921:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
19/11/201921:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
19/11/201921:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
19/11/201921:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
19/11/201921:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
19/11/201921:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:BLPH